109 related articles for article (PubMed ID: 25458474)
21. Report of a WHO workshop on the standardization and control of antivenoms.
Theakston RD; Warrell DA; Griffiths E
Toxicon; 2003 Apr; 41(5):541-57. PubMed ID: 12676433
[TBL] [Abstract][Full Text] [Related]
22. Current technology for the industrial manufacture of snake antivenoms.
León G; Vargas M; Segura Á; Herrera M; Villalta M; Sánchez A; Solano G; Gómez A; Sánchez M; Estrada R; Gutiérrez JM
Toxicon; 2018 Sep; 151():63-73. PubMed ID: 29959968
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of whole IgG equine antivenom: comparison between normal and envenomed rabbits.
Quesada L; Sevcik C; Lomonte B; Rojas E; Gutiérrez JM
Toxicon; 2006 Sep; 48(3):255-63. PubMed ID: 16863656
[TBL] [Abstract][Full Text] [Related]
24. Human heterophilic antibodies against equine immunoglobulins: assessment of their role in the early adverse reactions to antivenom administration.
León G; Segura A; Herrera M; Otero R; França FO; Barbaro KC; Cardoso JL; Wen FH; de Medeiros CR; Prado JC; Malaque CM; Lomonte B; Gutiérrez JM
Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1115-9. PubMed ID: 18561967
[TBL] [Abstract][Full Text] [Related]
25. Development of an improved method for production of antiscorpion F(ab')2 fragment of IgG with high yield and potency.
Seddik SS; Wanas S; Shehata A; Fawaz S; Helmy MH
J Nat Toxins; 2002 May; 11(2):123-32. PubMed ID: 12009112
[TBL] [Abstract][Full Text] [Related]
26. Cross-neutralisation of Australian brown snake, taipan and death adder venoms by monovalent antibodies.
Isbister GK; O'Leary MA; Hagan J; Nichols K; Jacoby T; Davern K; Hodgson WC; Schneider JJ
Vaccine; 2010 Jan; 28(3):798-802. PubMed ID: 19879227
[TBL] [Abstract][Full Text] [Related]
27. Effect of preservatives on IgG aggregation, complement-activating effect and hypotensive activity of horse polyvalent antivenom used in snakebite envenomation.
García M; Monge M; León G; Lizano S; Segura E; Solano G; Rojas G; Gutiérrez JM
Biologicals; 2002 Jun; 30(2):143-51. PubMed ID: 12127316
[TBL] [Abstract][Full Text] [Related]
28. Assessing the preclinical efficacy of antivenoms: from the lethality neutralization assay to antivenomics.
Gutiérrez JM; Solano G; Pla D; Herrera M; Segura Á; Villalta M; Vargas M; Sanz L; Lomonte B; Calvete JJ; León G
Toxicon; 2013 Jul; 69():168-79. PubMed ID: 23201503
[TBL] [Abstract][Full Text] [Related]
29. Clinical laboratory: enzyme immunoassay for the rapid clinical identification of snake venom.
Coulter AR; Harris RD; Sutherland SK
Med J Aust; 1980 May; 1(9):433-5. PubMed ID: 6993892
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the effect of Crotalus simus and Crotalus durissus ruruima venoms on the equine antibody response towards Bothrops asper venom: implications for the production of polyspecific snake antivenoms.
Dos-Santos MC; Arroyo C; Solano S; Herrera M; Villalta M; Segura A; Estrada R; Gutiérrez JM; León G
Toxicon; 2011 Feb; 57(2):237-43. PubMed ID: 21130107
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of health status of horses immunized with snake venom and montanide adjuvants, IMS 3012 (nanoparticle), ISA 206 and ISA 35 (emulsion based) during polyvalent snake antivenom production: hematological and biochemical assessment.
Waghmare AB; Salvi NC; Deopurkar RL; Shenoy PA; Sonpetkar JM
Toxicon; 2014 May; 82():83-92. PubMed ID: 24582735
[TBL] [Abstract][Full Text] [Related]
32. Intraspecific differences in the immunochemical reactivity and neutralization of venom from Argentinean Bothrops (Rhinocerophis) alternatus by specific experimental antivenoms.
Lanari LC; Alagón A; Costa de Oliveira V; Laskowicz RD; Boyer L; Lago NR; Alejandro A; de Roodt AR
Toxicon; 2014 Jul; 85():31-45. PubMed ID: 24769139
[TBL] [Abstract][Full Text] [Related]
33. A reduced immunization scheme to obtain an experimental anti-Loxosceles laeta ("violinist spider") venom.
de Roodt AR; Litwin S; Dokmetjian JC; Vidal JC
J Nat Toxins; 2002 Aug; 11(3):193-203. PubMed ID: 12182539
[TBL] [Abstract][Full Text] [Related]
34. What can be learned in the snake antivenom field from the developments in human plasma derived products?
Burnouf T
Toxicon; 2018 May; 146():77-86. PubMed ID: 29621528
[TBL] [Abstract][Full Text] [Related]
35. The application of laboratory-based analytical tools and techniques for the quality assessment and improvement of commercial antivenoms used in the treatment of snakebite envenomation.
Patra A; Herrera M; Gutiérrez JM; Mukherjee AK
Drug Test Anal; 2021 Aug; 13(8):1471-1489. PubMed ID: 34089574
[TBL] [Abstract][Full Text] [Related]
36. A new Pan African polyspecific antivenom developed in response to the antivenom crisis in Africa.
Laing GD; Renjifo JM; Ruiz F; Harrison RA; Nasidi A; Gutierrez JM; Rowley PD; Warrell DA; Theakston RD
Toxicon; 2003 Jul; 42(1):35-41. PubMed ID: 12893059
[TBL] [Abstract][Full Text] [Related]
37. Cross neutralization of common Southeast Asian viperid venoms by a Thai polyvalent snake antivenom (Hemato Polyvalent Snake Antivenom).
Leong PK; Tan CH; Sim SM; Fung SY; Sumana K; Sitprija V; Tan NH
Acta Trop; 2014 Apr; 132():7-14. PubMed ID: 24384454
[TBL] [Abstract][Full Text] [Related]
38. Cross neutralization of dangerous snake venoms from Africa and the Middle East using the VACSERA polyvalent antivenom. Egyptian Organization for Biological Products & Vaccines.
Seddik SS; Wanas S; Helmy MH; Hashem M
J Nat Toxins; 2002 Dec; 11(4):329-35. PubMed ID: 12503876
[TBL] [Abstract][Full Text] [Related]
39. Human plasma-derived immunoglobulin G fractionated by an aqueous two-phase system, caprylic acid precipitation, and membrane chromatography has a high purity level and is free of detectable in vitro thrombogenic activity.
Vargas M; Segura Á; Wu YW; Herrera M; Chou ML; Villalta M; León G; Burnouf T
Vox Sang; 2015 Feb; 108(2):169-77. PubMed ID: 25469648
[TBL] [Abstract][Full Text] [Related]
40. Improved purification and yield of the Egyptian snake Cerastes cerastes antitoxin by the use of caprylic acid.
Seddik SS; Malak GA; Helmy MH
J Nat Toxins; 2002 Dec; 11(4):323-8. PubMed ID: 12503875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
